ϟ
DOI: 10.1093/annonc/mdv591
¤ OpenAccess: Hybrid
This work has “Hybrid” OA status. This means it is free under an open license in a toll-access journal.
A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumors
Anthony W. Tolcher,Kyriakos P. Papadopoulos,Amita Patnaik,Keith Wilson,Sarah P. Thayer,James A. Zanghi,Abigael T. Gemo,W. Michael Kavanaugh,Harold Keer,Patricia LoRusso
Medicine
Tolerability
Hyperphosphatemia
2016
Loading...
- MLA
- APA
- Chicago
- IEEE
- Harvard
- BibTeX
Cite this:
Generate Citation
“A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumors” is a paper by Anthony W. Tolcher Kyriakos P. Papadopoulos Amita Patnaik Keith Wilson Sarah P. Thayer James A. Zanghi Abigael T. Gemo W. Michael Kavanaugh Harold Keer Patricia LoRusso published in 2016. It has an Open Access status of “hybrid”. You can read and download a PDF Full Text of this paper here.